Decoding mitochondrial nutrient-sensing programs in POMC neurons as key determinants of metabolic health

Projektinformationen

MITOSENSING

ID Finanzhilfevereinbarung: 725004

DOI

10.3030/725004

Projekt abgeschlossen

EK-Unterschriftsdatum 22 Februar 2017

Startdatum 1 April 2017

Enddatum 30 September 2022

Finanziert unter

• EXCELLENT SCIENCE - European Research Council (ERC)

Gesamtkosten

€ 1 999 573,00

EU-Beitrag

€ 1 999 573,00

Koordiniert durch

FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain

Periodic Reporting for period 4 - MITOSENSING (Decoding mitochondrial nutrient-sensing programs in POMC neurons as key determinants of metabolic health)

Berichtszeitraum: 2021-10-01 bis 2022-09-30

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

Obesity has reached epidemic dimensions worldwide causing major human and economic repercussions. However, and despite the magnitude of this health problem, non-invasive treatments are scarce and insufficient in terms of efficacy. This is the consequence of our limited understanding of the molecular mechanisms underlying energy balance control.

Nutrient-sensing by hypothalamic neurons is a crucial process to monitor the metabolic status of the organism and to coordinate adaptive responses to maintain energy homeostasis. Proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus are prototypical cellular sensors and key regulators of appetite, energy expenditure and metabolism. The hypothesis of MITOSENSING is that alterations in specific mitochondrial nutrient-sensing programs in POMC neurons cause energy balance defects that underlie the development of obesity and associated metabolic disorders such as type-2 diabetes (T2D).

The objectives are: 1) to identify transcriptionally-modulated mitochondrial nutrient-sensing programs in POMC neurons; 2) to investigate whether disruption of specific nutrient-sensing programs in POMC neurons cause metabolic disorders; 3) to investigate whether the development of lifestyle-associated metabolic disorders are caused by defective mitochondrial nutrient-sensing programs in POMC neurons.

Collectively, the results derived from this action evidenced that mitochondria in POMC neurons act as key signaling platforms integrating appetite, the metabolic function of peripheral tissues and cognitive performance.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

We have established the transcriptional signatures induced by glucose, Leucine and oleic acid in POMC neurons. We have also investigated the role of diverse mitochondrial functions in POMC neurons upon metabolic health. Our studies have revealed novel and unsuspected facets at the interface of appetite, peripheral metabolism control and cognitive performance. Furthermore, our research has also identified alterations in distinct transcriptional signatures of POMC neurons, in neonatal and perinatal developmental stages, associated with maternal obesogenic conditions. In conclusion, this action has provided novel insights on the role of mitochondria in POMC neurons in the context of highly prevalent metabolic conditions such as obesity and type-2 diabetes.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

MITOSENSING will represent a big step forward into the understanding of neuron type-specific nutrient-sensing programs in the context of obesity and metabolic alterations. The identification of such networks will open new and unexpected lines of investigation with potential therapeutical implications for obesity and T2D.

POMC neurons (green) in the arcuate nucleus of the hypothalamus